Literature DB >> 16454610

Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: a family study.

V Cadahía1, L Rodrigo, D Fuentes, S Riestra, R de Francisco, M Fernández.   

Abstract

We discuss the case of a 17-year-old male who at the age of 7 was diagnosed with celiac disease (CD) together with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC). The patient was treated with gluten-free diet and immunosuppressive drugs (azathioprine), and currently remains asymptomatic. The patient's younger, 12-year-old sister was diagnosed with CD when she was 1.5 years old, and at 7 years she developed type-I diabetes mellitus, which was difficult to control. A family study was made, and both parents were found to be affected with silent CD. All were DQ2 (+). In relation to the case and family study, we provide a series of comments related to CD and its complications.

Entities:  

Mesh:

Year:  2005        PMID: 16454610     DOI: 10.4321/s1130-01082005001200007

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  4 in total

1.  Celiac disease in a child with ulcerative colitis: a possible genetic association.

Authors:  Sam X Cheng; Aileen Raizner; Uma P Phatak; Judy H Cho; Dinesh S Pashankar
Journal:  J Clin Gastroenterol       Date:  2013-02       Impact factor: 3.062

2.  Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report.

Authors:  Josef Finsterer; Sonja Höflich
Journal:  J Med Case Rep       Date:  2010-11-08

Review 3.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 4.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.